Light Mode
$97.47 ↑ +0.00 (+0.00%) Trading Up from the previous close of $97.47, $0.52 below the day’s high of $97.99
+17.40 (+21.73%) / 6M
Momentum, market sentiment, and recent alerts
ZBH reads neutral: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -2.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.